MAF PHARMA LIMITEDActive

Company number SC361174Private limited companyIncorporated 2009

Key figures

£220,897+10.6%
Net assets 2025/26
-7.3%
Average annual change 2019/20–2025/26
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, MAF PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand28,57421,5922,6017,48010,441
Total assets300,870348,810368,215260,812240,671
Total liabilities83,485147,188140,70061,07919,774
Net assets / total equity217,385201,622227,515199,733220,897
Average number of employees77654

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MAF PHARMA LIMITED

Company

MAF PHARMA LIMITED is a private limited company registered with Companies House under company number SC361174. It was incorporated on 12 Jun 2009. Its status is active. The registered office is in Kirkcaldy (KY1). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), combined office administrative service activities (82110).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files small company accounts (filleted). Net assets were £220,897, up 10.6% on the previous year. Cash at bank and in hand was £10,441. Total assets were £240,671 and total liabilities £19,774. The company had an average of 4 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 29 Feb 2028. The next confirmation statement is due by 26 Jun 2027.